G. Cicala , G. Coratti , S. Paolucci , G. Baranello , J. Exposito Escudero , A. Wolfe , M. Brooke , S. Messina , F. Ricci , A. D'Amico , L. Bello , C. Bruno , V. Sansone , R. Masson , V. Nigro , M. Pane , A. Nascimento , F. Muntoni , E. Mercuri , on behalf of the Italian DMD network
{"title":"185PChanges in timed items in DMD patients amenable to skipping exons 44, 45, 51 and 53: a 24-month collaborative study","authors":"G. Cicala , G. Coratti , S. Paolucci , G. Baranello , J. Exposito Escudero , A. Wolfe , M. Brooke , S. Messina , F. Ricci , A. D'Amico , L. Bello , C. Bruno , V. Sansone , R. Masson , V. Nigro , M. Pane , A. Nascimento , F. Muntoni , E. Mercuri , on behalf of the Italian DMD network","doi":"10.1016/j.nmd.2025.105538","DOIUrl":null,"url":null,"abstract":"<div><div>This study explored 24-month changes in motor function among 458 ambulant boys with genetically confirmed Duchenne muscular dystrophy (DMD), using two timed items: 10-meter walk/run (10MWR) and time to rise from floor (TRF). Participants were recruited from Italian, UK, and Spanish networks and assessed at baseline, 12, 18, and 24 months. When exon-skipping subgroups were examined the 10MWR were overall stable, with minimal differences across skipping subtypes. In boys ≥7, all exon categories showed functional decline, with exon 51 showing the greatest deterioration. The TRF in contrast showed an increase in TRF, indicating a functional deterioration in both age groups across all exon categories with a more severe increase in boys ≥7, particularly for exons 51 and 53. Overall, the results show a different trend in the two-timed items. On one hand, the 10WR showed a profile consistent with previous reports in NSAA and 6MWT with overall stable results below the age of 7 years and little differences across skipping subgroups. On the other hand, in the TRF the deterioration could already be observed in the younger group and became more marked in the older ones. These findings emphasize the variability in early disease progression in boys with DMD.</div></div>","PeriodicalId":19135,"journal":{"name":"Neuromuscular Disorders","volume":"53 ","pages":"Article 105538"},"PeriodicalIF":2.8000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuromuscular Disorders","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0960896625002652","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
This study explored 24-month changes in motor function among 458 ambulant boys with genetically confirmed Duchenne muscular dystrophy (DMD), using two timed items: 10-meter walk/run (10MWR) and time to rise from floor (TRF). Participants were recruited from Italian, UK, and Spanish networks and assessed at baseline, 12, 18, and 24 months. When exon-skipping subgroups were examined the 10MWR were overall stable, with minimal differences across skipping subtypes. In boys ≥7, all exon categories showed functional decline, with exon 51 showing the greatest deterioration. The TRF in contrast showed an increase in TRF, indicating a functional deterioration in both age groups across all exon categories with a more severe increase in boys ≥7, particularly for exons 51 and 53. Overall, the results show a different trend in the two-timed items. On one hand, the 10WR showed a profile consistent with previous reports in NSAA and 6MWT with overall stable results below the age of 7 years and little differences across skipping subgroups. On the other hand, in the TRF the deterioration could already be observed in the younger group and became more marked in the older ones. These findings emphasize the variability in early disease progression in boys with DMD.
期刊介绍:
This international, multidisciplinary journal covers all aspects of neuromuscular disorders in childhood and adult life (including the muscular dystrophies, spinal muscular atrophies, hereditary neuropathies, congenital myopathies, myasthenias, myotonic syndromes, metabolic myopathies and inflammatory myopathies).
The Editors welcome original articles from all areas of the field:
• Clinical aspects, such as new clinical entities, case studies of interest, treatment, management and rehabilitation (including biomechanics, orthotic design and surgery).
• Basic scientific studies of relevance to the clinical syndromes, including advances in the fields of molecular biology and genetics.
• Studies of animal models relevant to the human diseases.
The journal is aimed at a wide range of clinicians, pathologists, associated paramedical professionals and clinical and basic scientists with an interest in the study of neuromuscular disorders.